Invasive Treatment Strategies in a Patient with PARK 15-Associated Parkinsonism.
作者信息
Spielberger Sabine, Seppi Klaus, Wolf Elisabeth, Eisner Wilhelm, Poewe Werner
机构信息
Department of Neurology Medical University Innsbruck Innsbruck Austria.
Department of Neurosurgery Medical University Innsbruck Innsbruck Austria.
出版信息
Mov Disord Clin Pract. 2015 Jul 25;2(4):434-435. doi: 10.1002/mdc3.12151. eCollection 2015 Dec.
Abstract
摘要
相似文献
1
Invasive Treatment Strategies in a Patient with PARK 15-Associated Parkinsonism.一名患有PARK 15相关帕金森症患者的侵入性治疗策略
Mov Disord Clin Pract. 2015 Jul 25;2(4):434-435. doi: 10.1002/mdc3.12151. eCollection 2015 Dec.
2
[Apomorphine in advanced Parkinson disease].[阿扑吗啡在晚期帕金森病中的应用]
Neurol Neurochir Pol. 2013 Sep-Oct;47(5):476-83. doi: 10.5114/ninp.2013.38227.
3
Excellent response to apomorphine in Parkinsonism with optic atrophy unresponsive to oral antiparkinsonian medication.帕金森病伴视神经萎缩患者对口服抗帕金森药物无反应，但对阿扑吗啡反应良好。
Mov Disord. 2006 Sep;21(9):1523-5. doi: 10.1002/mds.20975.
4
[Apomorphine therapy versus deep rain stimulation. Clinical and economic aspects in patients with advanced Parkinson disease].[阿扑吗啡疗法与深部脑刺激。晚期帕金森病患者的临床和经济方面]
Nervenarzt. 2001 Dec;72(12):924-7. doi: 10.1007/s001150170004.
5
[Improvement in swallowing difficulties treated by subcutaneous apomorphine infusion after deep brain stimulation in Parkinson's disease].[帕金森病深部脑刺激术后皮下注射阿扑吗啡治疗吞咽困难的疗效改善]
Rev Neurol (Paris). 2004 Mar;160(3):352-3. doi: 10.1016/s0035-3787(04)70913-3.
6
The role of subcutaneous infusion of apomorphine in Parkinson's disease.皮下注射阿扑吗啡在帕金森病中的作用。
Expert Rev Neurother. 2014 Jul;14(7):833-43. doi: 10.1586/14737175.2014.928202. Epub 2014 Jun 11.
7
Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.皮下注射阿扑吗啡：关于其在帕金森病中应用的循证综述
Drugs Aging. 2004;21(11):687-709. doi: 10.2165/00002512-200421110-00001.
8
Continuous subcutaneous apomorphine in advanced Parkinson's disease patients treated with deep brain stimulation.在接受脑深部电刺激治疗的晚期帕金森病患者中使用持续皮下阿朴吗啡。
J Neurol. 2019 Mar;266(3):659-666. doi: 10.1007/s00415-019-09184-5. Epub 2019 Jan 7.
9
Time course of tolerance to apomorphine in parkinsonism.帕金森病中对阿扑吗啡耐受性的时间进程。
Clin Pharmacol Ther. 1992 Nov;52(5):504-10. doi: 10.1038/clpt.1992.178.
10
[Apomorphine test: evaluation of dopaminergic response in patients with Parkinson disease].[阿扑吗啡试验：帕金森病患者多巴胺能反应的评估]
Rev Med Chil. 1995 Mar;123(3):326-9.
引用本文的文献
1
A Review on Response to Device-Aided Therapies Used in Monogenic Parkinsonism and GBA Variants Carriers: A Need for Guidelines and Comparative Studies.单基因帕金森病和 GBA 变异携带者对设备辅助治疗的反应综述：需要制定指南和开展比较研究。
J Parkinsons Dis. 2022;12(6):1703-1725. doi: 10.3233/JPD-212986.
本文引用的文献
1
Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.药物难治性颈肌张力障碍患者的苍白球神经刺激：一项随机、假手术对照试验。
Lancet Neurol. 2014 Sep;13(9):875-84. doi: 10.1016/S1474-4422(14)70143-7. Epub 2014 Aug 7.
2
F-box only protein 7 gene in parkinsonian-pyramidal disease.帕金森-锥体束疾病中的 F-box 仅蛋白 7 基因。
JAMA Neurol. 2013 Jan;70(1):20-4. doi: 10.1001/jamaneurol.2013.572.
3
FBXO7 mutations cause autosomal recessive, early-onset parkinsonian-pyramidal syndrome.FBXO7基因突变导致常染色体隐性遗传的早发性帕金森-锥体束综合征。
Neurology. 2009 Jan 20;72(3):240-5. doi: 10.1212/01.wnl.0000338144.10967.2b. Epub 2008 Nov 26.
4
Accuracy of stereotactic electrode placement in deep brain stimulation by intraoperative computed tomography.术中计算机断层扫描在脑深部电刺激中立体定向电极放置的准确性
Parkinsonism Relat Disord. 2008 Dec;14(8):595-9. doi: 10.1016/j.parkreldis.2008.01.008. Epub 2008 Mar 7.
Zotero 插件